339 related articles for article (PubMed ID: 16105068)
1. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
2. Effect of Scavenging Circulating Reactive Carbonyls by Oral Pyridoxamine in Uremic Rats on Peritoneal Dialysis.
Mori Y; Kakuta T; Miyakogawa T; Takekoshi S; Yuzawa H; Kobayashi H; Kawakami A; Miyata T; Fukagawa M
Ther Apher Dial; 2016 Dec; 20(6):645-654. PubMed ID: 27620210
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
5. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
[TBL] [Abstract][Full Text] [Related]
7. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.
Miyata T; Devuyst O; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 2002 Feb; 61(2):375-86. PubMed ID: 11849377
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.
Yuan J; Fang W; Ni Z; Dai H; Lin A; Cao L; Qian J
Pediatr Nephrol; 2009 Jan; 24(1):163-70. PubMed ID: 18751736
[TBL] [Abstract][Full Text] [Related]
9. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
10. [The effects of cyclooxygenase-2 inhibitors on peritoneal lymphangiogenesis and peritoneal function in uremic rats].
Xiao J; Guo J; Zhao ZH; Jin YF; Liu D; Zhao ZZ
Zhonghua Nei Ke Za Zhi; 2013 Dec; 52(12):1048-52. PubMed ID: 24503405
[TBL] [Abstract][Full Text] [Related]
11. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
13. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
[TBL] [Abstract][Full Text] [Related]
14. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
15. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.
Combet S; Ferrier ML; Landschoot MV; Stoenoiu M; Moulin P; Miyata T; Lameire N; Devuyst O
J Am Soc Nephrol; 2001 Oct; 12(10):2146-2157. PubMed ID: 11562414
[TBL] [Abstract][Full Text] [Related]
16. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
17. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
18. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.
Io H; Hamada C; Ro Y; Ito Y; Hirahara I; Tomino Y
Kidney Int; 2004 May; 65(5):1927-36. PubMed ID: 15086936
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane.
Noh H; Kim JS; Han KH; Lee GT; Song JS; Chung SH; Jeon JS; Ha H; Lee HB
Kidney Int; 2006 Jun; 69(11):2022-8. PubMed ID: 16641917
[TBL] [Abstract][Full Text] [Related]
20. Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients.
Ishida M; Kakuta T; Miyakogawa T; Tatsumi R; Matsumoto C; Fukagawa M
Tokai J Exp Clin Med; 2016 Jun; 41(2):97-100. PubMed ID: 27345001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
